Make Health My Homepage
More Ways to Get Health!
gift newsletter igoogle healthyvoice
Journey

AstraZeneca & Commitment


This is a sponsored resource. Early Breast Cancer content provided by AstraZeneca

AstraZeneca & Commitment  

At AstraZeneca, we're committed to helping women with breast cancer get treatment and support. For over 30 years, AstraZeneca has been at the forefront of the fight against cancer, and continues to be a pioneer in cancer research and treatment.

»AstraZeneca's patient support programs and educational programs
IN YOUR CORNERHealth.com Celebration ChainHealth.com Your Well-BeingHealth.com Meet the Leading LadiesHealth.com Breast Cancer ResourcesHealth.com


   

IN YOUR CORNER™A patient support program designed especially for women taking ARIMIDEX® (anastrozole) Tablets.

»Learn more


 

CELEBRATION CHAIN™Know someone who has breast cancer?
Brighten up their day.

»Create a Celebration Doll


 

 

MEET THE LEADING LADIESWatch twenty patients with breast cancer as
they share their stories and diverse opinions
about their fight against breast cancer.
Gain insight. Get inspired.

»Learn from others


 



Important Information About ARIMIDEX® (anastrozole) Tablets

ARIMIDEX is approved for adjuvant treatment (treatment following surgery with or without radiation) of postmenopausal women with hormone receptor-positive early breast cancer.

Important Safety Information About ARIMIDEX

Prescription ARIMIDEX is only for postmenopausal women. ARIMIDEX should not be taken if you are pregnant because it may harm your unborn child.

Based on information from a study in patients with early breast cancer, women with a history of blockages in heart arteries (ischemic heart disease) who take ARIMIDEX may have a slight increase in this type of heart disease compared to similar patients who take tamoxifen.

ARIMIDEX can cause bone softening/weakening (osteoporosis) increasing the chance of fractures. In a clinical study in early breast cancer, there were more fractures (including fractures of the spine, hip, and wrist) with ARIMIDEX (10%) than with tamoxifen (7%).

In a clinical study in early breast cancer, some patients taking ARIMIDEX had an increase in cholesterol. Skin reactions, allergic reactions, and changes in blood tests of liver function have also been reported.

In the early breast cancer clinical trial, the most common side effects seen with ARIMIDEX include hot flashes, joint symptoms (including arthritis and arthralgia), weakness, mood changes, pain, back pain, sore throat, nausea and vomiting, rash, depression, high blood pressure, osteoporosis, fractures, swelling of arms/legs, insomnia, and headache.

ARIMIDEX should not be taken with tamoxifen or estrogen-containing therapies.

Please click here for full Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.

ARIMIDEX is a registered trademark and Celebration Chain and IN YOUR CORNER are trademarks of the AstraZeneca group of companies.

©2009 AstraZeneca Pharmaceuticals LP. All rights reserved. 268668 7/09

AstraZeneca

Text Size: Decrease Increase

Advertisement